HHS’ Office for Civil Rights Settles HIPAA Investigation of Ambry Genetics for Security Rule Violations
HHS Office for Civil Rights reached a settlement with Ambry Genetics, a California-based genetic testing company, over alleged violations of the HIPAA Security Rule. The settlement follows an OCR investigation into how Ambry handled protected health information.
Why this matters: Genetic data is about as sensitive as personal information gets. It does not just identify you — it can reveal health risks, family relationships, and hereditary conditions you may not even know about yet. When a genetics company fails HIPAA security standards, the people exposed did not just hand over a name and email. They handed over their biological blueprint. Settlements like this put money on the board, but the real measure is whether the company's security actually changes.
Who should care: Lawyers · Privacy officers · Compliance · Healthcare professionals
This summary is AI-assisted and may contain errors. It is an original briefing to help you gauge significance quickly — not a reproduction of the source. Always read the linked original before relying on it. See our methodology.